SCHEMBL25455136

SCHEMBL25455136

C=CCOc1cccc(CC(C)(C)C)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
GAA P10253 2/20 0.45
BCHE P06276 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
EGFR P00533 1/20 0.39
ERBB2 P04626 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GGPS1 O95749 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27718099 0.88 KDM4E (0.47) KDM4ENPC1RAB9AGAABCHE
SCHEMBL31267723 0.82 BCHE (0.49) KDM4ENPC1RAB9AGAABCHE
SCHEMBL20482022 0.81 KDM4E (0.49) KDM4ENPC1RAB9AGAABCHE
SCHEMBL723458 0.81 BCHE (0.53) KDM4ENPC1RAB9AGAABCHE
SCHEMBL22215905 0.81 KDM4E (0.51) KDM4ENPC1RAB9AGAABCHE
SCHEMBL12775724 0.80 TP53 (0.56) KDM4EBCHEALDH1A1CYP1A2CYP3A4
SCHEMBL16841500 0.80 GGPS1 (0.41) KDM4EBCHEALDH1A1CYP3A4SMN1; SMN2
SCHEMBL2318952 0.80 KDM4E (0.50) KDM4ENPC1RAB9AGAABCHE
SCHEMBL4456470 0.80 ALDH1A1 (0.50) KDM4ENPC1RAB9AMEN1KMT2A
SCHEMBL1520719 0.78 MEN1 (0.50) KDM4ENPC1RAB9AGAABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF FEM1B, GSKIP, FNIP1 KDM4E 2287/4885NPC1 3656/4885RAB9A 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.